Cognitive profiles in persons with depressive disorder and Alzheimer's disease. Issue 2 (27th November 2020)

• Record Type: Journal Article
• Authors: Lanza, Claudia; Sejunaite, Karolina; Steindel, Charlotte; Scholz, Ingo; Riepe, Matthias W
• Is Part Of: Brain communications. Volume 2:Issue 2(2020)
• Publication Date: 2020-11-27
• Subjects: Alzheimer's disease -- depression -- cognition -- biomarkers -- neuropsychology; 616
• DOI: 10.1093/braincomms/fcaa206
• Languages: English
• ISSNs: 2632-1297

Abstract

Abstract: Alzheimer's disease and depressive disorder are frequent in old age. Both may be associated with depressed mood and cognitive impairment. Therefore, finding a strategy to clarify the diagnosis underlying subjective complaints of impaired cognition and depressed mood in older persons is of utmost interest. We conducted a cross-sectional retrospective observational clinical cohort study using patient records from 2014 to 2018. From 3758 patients, we included patients aged 60 years and older with a Mini-Mental-Status Examination score of 24 and above. Final analysis included all patients in whom Alzheimer's disease biomarker analysis was performed (cerebrospinal fluid markers of Alzheimer's disease or positron emission tomography imaging; n = 179) and patients with depressive disorder in whom Alzheimer's disease was ruled out by analysis of biomarkers suggestive of Alzheimer's disease ( n = 70). With case–control matching for age, education and gender, performance of patients with Alzheimer's disease was worse in acquisition, consolidation and recall of verbal information and false-positive answers. None of the results, however, sufficed to differentially diagnose individual patients with Alzheimer's disease or depressive disorder. With more severe symptoms of depression, patients with biomarker-verified Alzheimer's disease performed worse in executive testing but were not additionally impaired in verbal episodic memory performance. We conclude that distinguishing between Alzheimer's disease and depressive disorder is unreliable on clinical grounds and behavioural testing alone. Diagnosing the cause of subjective complaints about deteriorating cognitive function or depressed mood requires additional biomarker assessment, whereas cognitive assessment is needed to define appropriate targets of symptomatic treatment in patients with Alzheimer's disease and depressive disorder. Abstract : Both Alzheimer's disease and depressive disorder may be associated with depressed mood and cognitive impairment. Distinguishing between the two conditions on clinical and behavioural grounds alone is unreliable. Diagnosing the cause of subjective complaints about deteriorating cognitive function or depressed mood requires additional biomarker assessment. Graphical Abstract: